PA
DCPH

Perceptive Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Perceptive Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,326
Closed -$892K – 130
2019
Q4 		$892K Buy
+14,326
New +$681K 0.02% 98
2018
Q1 		– Sell
-102,500
Closed -$2.32M – 156
2017
Q4 		$2.32M Hold
102,500
– – 0.08% 88
2017
Q3 		$1.95M Buy
+102,500
New +$1.88M 0.07% 94

Other funds holding DCPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Perceptive Advisors's DCPH Position: Q1 2020 in Review

Perceptive Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2020, closing a stake of 14,326 shares — an estimated $892K sold.

Perceptive Advisors first reported a position in DCPH in Q3 2017 and held it in 3 quarters. The position peaked at $2.32M in Q4 2017. 148 funds tracked by Wall St. Rank hold DCPH as of Q1 2020.

  • Perceptive Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Perceptive Advisors sold 14,326 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $892K.
  • Perceptive Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 3 quarters.
  • Perceptive Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.32M in Q4 2017.
  • 148 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Perceptive Advisors's 13F filing for Q1 2020, filed 15 May 2020.